Revolution Medicines · 4 hours ago
Director, Biostatistics
San Francisco Bay Area
Full-time
Onsite
Director/Executive
$204K/yr - $255K/yr
8+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Director of Biostatistics will provide statistical leadership for clinical development strategy and studies, collaborating across functions to ensure effective study design and regulatory compliance.
Health CareLife ScienceMedical
Responsibilities
Provide statistical support and strategic input to clinical development plans and target product profiles, proof of concept criteria, and team’s preparation for company governance reviews
Represent Biostatistics function on cross-function teams at program level and serve as a lead statistician for oncology studies
Collaborate with various functions on study design and planning, protocol development, statistical analysis plan and analysis specifications
Provide statistical support for study protocol development, analysis plan and specification through direct involvement and/or providing guidance to junior staff
Plan and prepare independent data monitoring committee (DMC), coordinate with independent statistical data analysis center for DMC and study team for periodic DMC reviews
Collaborate with data management and clinical operations over the course of clinical studies to provide statistical input to study conducts and database development as well as data collection and cleaning activities
Collaborate with statistical programming to ensure that appropriate programs and documentations are being developed for datasets development and outputs generation, and ensure the statistical analyses specified in scientific protocols and/or analysis plans are conducted appropriately
Provide statistical input and leadership to the development of global health authority documents, regulatory interaction and response to health authority submissions
Provide statistical support for clinical publications, assist in data interpretation to ensure consistency and accuracy in data presentation
Drive and lead department initiatives, best practices, and guidelines
Keep abreast in new developments in statistics, drug development, and regulatory guidance and share knowledge with functional and cross-functional team members
Qualification
Required
D. or M.S. in Statistics/Biostatistics, a minimum of 8 years (for Ph.D.) and 12 years (for M.S.) of experience in the biotech/pharma industry as a statistician. Level will be determined based on the relevance of experience
Hands-on experience in design and analysis of oncology trials is a must
Ability to work independently and within a team
Solid knowledge in ICH and other regulatory requirements related to biostatistical activities and clinical trials
Excellent verbal and written communication skills are required
Good interpersonal and project management skills are essential
Proficiency in SAS and/or R
Preferred
Active participation in NDA/BLA filing through label negotiations desirable
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase